Isoangustone AIsoangustone A
MedChemExpress (MCE)
HY-N4006
129280-34-8
96.0%
-20°C, protect from light *In solvent : -80°C, 6 months
-20°C, 1 month (protect from light)
Room temperature in continental US
may vary elsewhere.
Isoangustone A is an anticancer and anti-inflammatory agent. Isoangustone A induces cancer cells apoptosis and autophagic cell death.
Isoangustone A (10 and 20 μM
48 and 72 h) suppresses proliferation and induces G1 phase cell cycle arrest in SK-MEL-28 cells[1]. Isoangustone A (10 and 20 μM
48 h) decreases the abundance of G1 phase-related proteins mediated through the Akt/GSK3β and MKK4/MKK7/JNKs signaling pathways[1]. Isoangustone A suppresses PI3-K, MKK4, and MKK7 kinase activities by directly binding in an ATP-competitive manner[1]. Isoangustone A (20 μM
0.5-4 h) induces autophagy in colorectal cancer cells by activating AMPK signaling[2]. Isoangustone A (1-20 μM
0-100 min) inhibits mitochondrial respiration[2]. Isoangustone A (15 μM
6 h) induces SW480 cells apoptosis[2]. Isoangustone A (1-20 μΜ
3 days) suppresses mesangial fibrosis and inflammation in human renal mesangial cells[3].
Isoangustone A (2 or 10 mg/kg
i.p.
daily for 35 days) significantly decreases tumor growth, volume, and weight of SK-MEL-28 xenografts in mice[1].
Apoptosis, Autophagy[2] Cellular Effect Cell Line Type Value Description References
| | | |
| | | | | |
[1]. Song NR, et al. Isoangustone A, a novel licorice compound, inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma. Cancer Prev Res (Phila). 2013 Dec
6(12):1293-303. [Content Brief]
[2]. Tang S, et al. Isoangustone A induces autophagic cell death in colorectal cancer cells by activating AMPK signaling. Fitoterapia. 2021 Jul
152:104935. [Content Brief]
[3]. Li J, et al. Isoangustone A suppresses mesangial fibrosis and inflammation in human renal mesangial cells. Exp Biol Med (Maywood). 2011 Apr 1
236(4):435-44. [Content Brief]